| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Katsuhiro Nagatomo, Sechiko Suga, Masato Saitoh, Masahito Kogawa, Kazuto Kobayashi, Yoshio Yamamoto, Katsuya Yamad. Dopamine D1 Receptor Immunoreactivity on Fine Processes of GFAP-Positive Astrocytes in the Substantia Nigra Pars Reticulata of Adult Mouse. Frontiers in neuroanatomy. vol 11. 2020-09-30. PMID:28203148. |
substantia nigra pars reticulata (snr), the major output nucleus of the basal ganglia, receives dopamine from dendrites extending from dopaminergic neurons of the adjacent nucleus pars compacta (snc), which is known for its selective degeneration in parkinson's disease. |
2020-09-30 |
2023-08-13 |
mouse |
| James Robert Brašić, Zoltan Mari, Alicja Lerner, Vanessa Raymont, Eram Zaidi, Dean F Won. Remission of Gilles de la Tourette Syndrome after Heat-Induced Dehydration. International journal of physical medicine & rehabilitation. vol 6. issue 3. 2020-09-30. PMID:30090843. |
the heat exposure may have altered at least temporarily his thermostat for normal heat-loss mechanisms through dopaminergic pathways from the anterior hypothalamus to the basal ganglia and the substantia nigra. |
2020-09-30 |
2023-08-13 |
Not clear |
| Brian C Clark, Adam J Woods, Leatha A Clark, Cody R Criss, Reza Shadmehr, Dustin R Groom. The Aging Brain & the Dorsal Basal Ganglia: Implications for Age-Related Limitations of Mobility. Advances in geriatric medicine and research. vol 1. 2020-09-28. PMID:31497780. |
here, we discuss the potential role of the motor control circuit of the dorsal basal ganglia as well as dopaminergic function in age-related reductions in mobility. |
2020-09-28 |
2023-08-13 |
Not clear |
| Karim Johari, Matthew Walenski, Jana Reifegerste, Farzad Ashrafi, Roozbeh Behroozmand, Mostafa Daemi, Michael T Ullma. A dissociation between syntactic and lexical processing in Parkinson's disease. Journal of neurolinguistics. vol 51. 2020-09-28. PMID:31777416. |
parkinson's disease (pd), which involves the degeneration of dopaminergic neurons in the basal ganglia, has long been associated with motor deficits. |
2020-09-28 |
2023-08-13 |
human |
| Karim Johari, Matthew Walenski, Jana Reifegerste, Farzad Ashrafi, Roozbeh Behroozmand, Mostafa Daemi, Michael T Ullma. A dissociation between syntactic and lexical processing in Parkinson's disease. Journal of neurolinguistics. vol 51. 2020-09-28. PMID:31777416. |
finally, few studies have examined links between syntactic/lexical impairments and their neurocognitive substrates, such as measures of basal ganglia degeneration or dopaminergic processes. |
2020-09-28 |
2023-08-13 |
human |
| Rafael Gonzalo-Gobernado, Diana Reimers, María José Casarejos, Lucía Calatrava Ferreras, Manuela Vallejo-Muñoz, Adriano Jiménez-Escrig, Juan José Diaz-Gil, Gonzalo M Ulzurrun de Asanza, Eulalia Bazá. Liver Growth Factor Induces Glia-Associated Neuroprotection in an In Vitro Model of Parkinson´s Disease. Brain sciences. vol 10. issue 5. 2020-09-28. PMID:32455921. |
parkinson's disease is a neurodegenerative disorder characterized by the progressive death of dopaminergic (da) neurons in the substantia nigra (sn), which leads to a loss of the neurotransmitter dopamine in the basal ganglia. |
2020-09-28 |
2023-08-13 |
rat |
| Han-A Park, Amy C Elli. Dietary Antioxidants and Parkinson's Disease. Antioxidants (Basel, Switzerland). vol 9. issue 7. 2020-09-28. PMID:32630250. |
parkinson's disease (pd) is a neurodegenerative disorder caused by the depletion of dopaminergic neurons in the basal ganglia, the movement center of the brain. |
2020-09-28 |
2023-08-13 |
Not clear |
| Andreas Klaus, Joaquim Alves da Silva, Rui M Cost. What, If, and When to Move: Basal Ganglia Circuits and Self-Paced Action Initiation. Annual review of neuroscience. vol 42. 2020-09-10. PMID:31018098. |
here we review studies and models of how direct and indirect pathways can modulate basal ganglia outputs to facilitate movement initiation, and we discuss the role of cortical and dopaminergic inputs to the striatum in determining what to do and if and when to do it. |
2020-09-10 |
2023-08-13 |
Not clear |
| Maaike M H van Swieten, Rafal Bogac. Modeling the effects of motivation on choice and learning in the basal ganglia. PLoS computational biology. vol 16. issue 5. 2020-08-07. PMID:32453725. |
a key role in this process is played by the basal ganglia, where neural activity and plasticity are modulated by dopaminergic input from the midbrain. |
2020-08-07 |
2023-08-13 |
Not clear |
| Nathan D Beu, Nicholas R Burns, Irina Baet. Polymorphisms in dopaminergic genes predict proactive processes of response inhibition. The European journal of neuroscience. vol 49. issue 9. 2020-07-14. PMID:30586202. |
it is well-established that response inhibition relies on the dopaminergic system in the basal ganglia. |
2020-07-14 |
2023-08-13 |
human |
| Fanni F Geibl, Martin T Henrich, Wolfgang H Oerte. Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease. Journal of neural transmission (Vienna, Austria : 1996). vol 126. issue 4. 2020-06-26. PMID:30643975. |
neurodegeneration of the nigrostriatal dopaminergic system and concurrent dopamine (da) deficiency in the basal ganglia represent core features of parkinson's disease (pd). |
2020-06-26 |
2023-08-13 |
Not clear |
| Urmas Roostalu, Casper B G Salinas, Ditte D Thorbek, Jacob L Skytte, Katrine Fabricius, Pernille Barkholt, Linu M John, Vanessa Isabell Jurtz, Lotte Bjerre Knudsen, Jacob Jelsing, Niels Vrang, Henrik H Hansen, Jacob Hecksher-Sørense. Quantitative whole-brain 3D imaging of tyrosine hydroxylase-labeled neuron architecture in the mouse MPTP model of Parkinson's disease. Disease models & mechanisms. vol 12. issue 11. 2020-05-28. PMID:31704726. |
parkinson's disease (pd) is a basal ganglia movement disorder characterized by progressive degeneration of the nigrostriatal dopaminergic system. |
2020-05-28 |
2023-08-13 |
mouse |
| Hailan Hu, Yihui Cui, Yan Yan. Circuits and functions of the lateral habenula in health and in disease. Nature reviews. Neuroscience. vol 21. issue 5. 2020-05-11. PMID:32269316. |
the lhb, sometimes referred to as the brain's 'antireward centre', receives inputs from diverse limbic forebrain and basal ganglia structures, and targets essentially all midbrain neuromodulatory systems, including the noradrenergic, serotonergic and dopaminergic systems. |
2020-05-11 |
2023-08-13 |
Not clear |
| Salil Patel, James J Fitzgerald, Chrystalina A Antoniade. Oculomotor effects of medical and surgical treatments of Parkinson's disease. Progress in brain research. vol 249. 2020-05-07. PMID:31325988. |
saccades-ballistic eye movements-are known to be affected by dopaminergic cell loss in the basal ganglia, caused by parkinson's disease. |
2020-05-07 |
2023-08-13 |
Not clear |
| Cuizhen Liu, Bo Cao, Rongjun Yu, Kang Si. Basal ganglia volumetric changes in psychotic spectrum disorders. Journal of affective disorders. vol 255. 2020-05-05. PMID:31153051. |
basal ganglia are particularly important for understanding the pathobiology of psychosis given their key roles in dopaminergic neurotransmission which are associated with psychotic symptoms and one of the target sites of antipsychotic drugs. |
2020-05-05 |
2023-08-13 |
Not clear |
| Himadri Shekhaar Baul, Ceera Manikandan, Dwaipayan Se. Cannabinoid receptor as a potential therapeutic target for Parkinson's Disease. Brain research bulletin. vol 146. 2020-03-10. PMID:30664919. |
parkinson's disease (pd) is the second most prevalent neurodegenerative disease, characterized by the loss of dopaminergic neurons from substantia nigra pars compacta of basal ganglia caused due to gene mutation, misfolded protein aggregation, reactive oxygen species generation and inflammatory stress. |
2020-03-10 |
2023-08-13 |
Not clear |
| Utkarsha A Singh, Soumya Iyenga. The expression of DARPP-32 in adult male zebra finches (Taenopygia guttata). Brain structure & function. vol 224. issue 8. 2020-02-24. PMID:31473781. |
our results suggest that whereas dopamine may modulate the shell pathways at various levels of the afp, dopaminergic modulation of the core pathway occurs mainly through area x, a basal ganglia nucleus. |
2020-02-24 |
2023-08-13 |
Not clear |
| Weitong Cui, Yuxi Zhan, Xiaoru Shao, Wei Fu, Dexuan Xiao, Junyao Zhu, Xin Qin, Tianyi Zhang, Mei Zhang, Yi Zhou, Yunfeng Li. Neuroprotective and Neurotherapeutic Effects of Tetrahedral Framework Nucleic Acids on Parkinson's Disease ACS applied materials & interfaces. vol 11. issue 36. 2020-02-11. PMID:31424187. |
pd is caused by dysfunction of basal ganglia, decrease of dopaminergic neurons in substantia nigra, and abnormal accumulation of lewy bodies and lewy neurites. |
2020-02-11 |
2023-08-13 |
Not clear |
| Esther Lara-González, Mariana Duhne, Fátima Ávila-Cascajares, Silvia Cruz, José Barga. Comparison of Actions between L-DOPA and Different Dopamine Agonists in Striatal DA-Depleted Microcircuits In Vitro: Pre-Clinical Insights. Neuroscience. vol 410. 2020-01-31. PMID:31078685. |
parkinson's disease (pd) is a neurodegenerative illness presenting motor and non-motor symptoms due to the loss of dopaminergic terminals in basal ganglia, most importantly, the striatum. |
2020-01-31 |
2023-08-13 |
Not clear |
| Petra Fischer, Alek Pogosyan, Alexander L Green, Tipu Z Aziz, Jonathan Hyam, Thomas Foltynie, Patricia Limousin, Ludvic Zrinzo, Michael Samuel, Keyoumars Ashkan, Mauro Da Lio, Mariolino De Cecco, Alberto Fornaser, Peter Brown, Huiling Ta. Beta synchrony in the cortico-basal ganglia network during regulation of force control on and off dopamine. Neurobiology of disease. vol 127. 2020-01-09. PMID:30849510. |
we recorded scalp eeg and basal ganglia local field potentials in parkinson's disease patients (11 stn, 7 gpi) on and off dopaminergic medication while they performed a visually-guided force matching task using a pen on a force-sensitive graphics tablet. |
2020-01-09 |
2023-08-13 |
Not clear |